ALB and cancer: Consequently, we hypothesized that attachment of BSO to a platinum(IV) prodrug has the potential to improve its pharmacokinetics and tumor specificity, especially when using an albumin-binding maleimide moiety, which is well-known to increase both, plasma half-life and cancer targeting14.